Business Wire

CA-LASERFICHE

4.6.2024 16:01:28 CEST | Business Wire | Press release

Share
Laserfiche Recognized as a 2024 Gartner® Peer Insights™ Customers’ Choice for Content Services Platforms

Laserfiche — the leading SaaS provider of intelligent content management and business process automation — has been named a Customers’ Choice in the 2024 Gartner Peer Insights ‘Voice of the Customer’: Content Services Platforms report. This distinction is based on customer reviews and given to vendors who meet or exceed both the market average Overall Experience and the market average User Interest and Adoption.

“Thanks to our customers, we're excited to be in the upper-right quadrant of the ‘Voice of the Customer’ with the highest overall rating and number of reviews,” said Laserfiche SVP of Corporate Strategy and CIO Thomas Phelps IV. “At Laserfiche, we’re passionate about our customers and are deeply committed to product innovation and an outstanding customer experience.”

In the Gartner report, Laserfiche received the highest average overall rating (4.7 out of 5), based on 404 reviews as of March 31, 2024. Laserfiche had the highest percentage of 5-star ratings among the seven recognized vendors.

Gartner Peer Insights is a free peer review and ratings platform designed for enterprise software and services decision makers. Reviews are organized by products in live markets that align to Gartner research markets, defined as Magic Quadrant or Market Guide-defined markets, or GPI-defined markets that are opened at the discretion of the GPI team and do not require research published to open the space on Peer Insights.

According to Gartner, “Content services platforms (CSPs) are foundational for managing and utilizing content within an organization. CSP technologies enable employees to retrieve and work with content in a modern and seamless way across devices and organizational boundaries. Core CSP functionalities include content capture, creation, consolidation, processing and retention to support personal, team, departmental and enterprise business operations.”

“The City of Riverside relies on innovative technology partners to power our virtual City Hall services and deliver world-class service to City departments and constituents,” said Riverside CIO George Khalil. “Our collaboration with Laserfiche is a great example of a public-private partnership that elevates our approach to public service. From digitally accessible records to paperless operations, data capture and processing, this partnership greatly enhances operations, transparency and customer service through our virtual City Hall, which offers 24/7 self-service access.”

Highlights of Gartner® Peer Insights™ reviews that contributed to Laserfiche’s recognition included:

  • “Laserfiche is like a Swiss Army knife of potential solutions. It is incredible how many problems it can solve. From automatic OCRing of documents, to workflows, to simple forms that replace paper — Laserfiche can do it all.” — Applications Specialist in the Government Industry
  • “Laserfiche is an incredibly robust forms solution that allows us to provide innovative automated processes and to improve existing legacy business processes. We have been thrilled with this product.” — IT Manager in the Healthcare and Biotech Industry
  • “We have used this vendor for over 25 years and it has become our second most important application at our institution.” — CIO in the Banking Industry

“These reviews provide hundreds of authentic, first-hand insights about why people love to use Laserfiche software,” said Laserfiche Director of Strategic Partnerships Kurt Rapelje. “They exemplify how organizations Run Smarter® with Laserfiche®.”

Laserfiche continues to deliver the solutions that offer business value and inspire customers to maximize their return on investment. The company recently announced Laserfiche AI to nearly 2,000 registered attendees at its annual Empower conference in April 2024. In addition, Laserfiche showcased the Laserfiche Solution Marketplace, a collection of more than 200 solution templates with downloadable tools for rapid deployment of automated solutions.

To learn more about how customers rated Laserfiche, download a complimentary copy of the 2024 Gartner Peer Insights ‘Voice of the Customer’: Content Services Platforms report here.

About Gartner Peer Insights

Gartner Peer Insights is a free peer review and ratings platform designed for enterprise software and services decision makers. The “Voice of the Customer” is a document that applies a methodology to aggregated Gartner Peer Insights’ reviews in a market to provide an overall perspective for IT decision makers. For more information, please visit www.gartner.com/reviews/home.

Gartner, Voice of the Customer for Content Services Platforms, Peer Contributors, 24 May 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, PEER INSIGHTS is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

Gartner Disclaimers

Gartner® and Peer Insights™ are trademarks of Gartner, Inc. and/or its affiliates. All rights reserved. Gartner® Peer Insightscontent consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.

About Laserfiche

Laserfiche is the leading SaaS provider of intelligent content management and business process automation. Through powerful workflows, electronic forms, document management and analytics, the Laserfiche® platform accelerates how business gets done, enabling leaders to focus on growth across the enterprise.

Laserfiche pioneered the paperless office with enterprise content management. Today, Laserfiche’s cloud-first development approach incorporates innovations in machine learning and AI to enable organizations in more than 80 countries to transform into digital businesses. Customers in every industry — including government, education, financial services, healthcare and manufacturing — use Laserfiche to boost productivity, scale their business and deliver digital-first customer experiences.

Laserfiche employees in offices around the world are committed to the company’s vision of empowering customers and inspiring people to reimagine how technology can transform lives.

Connect with Laserfiche:
Laserfiche Blog | Twitter | LinkedIn | Facebook

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604434491/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release

Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin

DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release

Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye